The Inositol Deficiency Hypothesis: Reclaiming Cellular Signaling

Why do some women with PCOS have a normal diet but still exhibit insulin resistance? The answer may lie in the 'Inositol Deficiency Hypothesis.' Inositols are carbocyclic sugars that function as secondary messengers in cellular signalling. When insulin binds to its receptor on the cell surface, it triggers the release of inositol phosphoglycans (IPGs). These IPGs are the 'delivery drivers' that go inside the cell to tell the GLUT4 transporters to come to the surface and let glucose in. In many women with PCOS, this messenger system is broken.

There is a systemic deficiency in Myo-inositol (MI) or a failure in the enzyme epimerase, which converts MI into D-chiro-inositol (DCI). In the ovaries, MI is crucial for the action of Follicle-Stimulating Hormone (FSH). Without adequate MI, the egg does not receive the signal to mature, regardless of how much FSH the pituitary produces. This results in poor oocyte quality and anovulation. Interestingly, the ovary maintains a specific 40:1 ratio of MI to DCI.

While DCI is necessary for insulin-mediated glycogen synthesis, too much DCI in the ovary—often caused by high systemic insulin—can actually inhibit the uptake of MI, creating a local deficiency that prevents ovulation. This is the 'DCI Paradox.' While the NHS continues to prescribe Metformin, which helps with systemic insulin sensitivity, it does not address the specific secondary messenger needs of the oocyte. Comparative studies, such as those published in 'European Review for Medical and Pharmacological Sciences,' suggest that Myo-inositol supplementation can be as effective as Metformin in improving insulin sensitivity but with significantly fewer gastrointestinal side effects and better outcomes for pregnancy rates. For the health-educated adult, understanding inositol is about understanding signal transduction. It is not about 'fixing' a hormone, but about ensuring the cell can 'hear' the hormones already present.

Supplementation with a 40:1 MI/DCI blend, alongside a diet that supports the inositol-dependent pathways, offers a biologically targeted way to restore the ovulatory cycle.